Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A structured framework for optimizing surgical quality through process-of-care trials.

Nikhil Waingankar1, Nestor F Esnaola2, Robert G Uzzo2

  • 1Department of UrologyDepartment of Population Health Science and Policy Icahn School of MedicineThe Mount Sinai HospitalNew York, NY; Department of Surgical Oncology Fox Chase Cancer Center - Temple Health Philadelphia, PA.

Urologic Oncology
|October 18, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

The New England journal of medicine·2026
Same author

Letter: Minimally Invasive Partial Versus Radical Nephrectomy for cT2 RCC: A National Matched-Pair Analysis.

The Journal of urology·2026
Same author

T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2<sup>+</sup> solid and hematologic cancers.

Nature communications·2026
Same author

Mucinous tubular and spindle cell carcinoma with papillae: A report of 5 cases and comparison with 18 cases of papillary renal cell carcinoma.

Human pathology·2025
Same author

Bladder Cancer with Undetectable Circulating Tumor DNA After Radical Cystectomy May Be Amenable to a Less Intense Imaging Surveillance Protocol: A Diagnostic Accuracy Study.

European urology oncology·2025
Same author

Efficacy of Bacillus Calmette-Guérin compared to sequential gemcitabine and docetaxel in Ta high-grade non-muscle invasive bladder cancer.

World journal of urology·2025

Surgical process-of-care trials are gaining traction nationally to enhance healthcare quality. These trials aim to improve patient care and the overall culture within surgical departments and hospitals by mitigating risks.

Area of Science:

  • Healthcare quality improvement
  • Surgical process optimization
  • Clinical trial methodology

Background:

  • Growing national emphasis on healthcare quality and care delivery processes.
  • Increasing use of surgical process-of-care trials at institutional levels.
  • These trials offer an alternative to traditional randomized treatment trials.

Purpose of the Study:

  • To highlight the significance of surgical process-of-care trials.
  • To underscore their role in improving patient care.
  • To demonstrate their potential to enhance the culture of surgical departments and healthcare systems.

Main Methods:

  • Focus on controlling and mitigating provider- and system-based risks.
  • Comparison with traditional randomized treatment trials.
Keywords:
Care deliveryIntegrated systemsOutcomesProcess measuresProcess-of-care trialsQualityRandomized trialsRiskSurgery

Related Experiment Videos

  • Implementation at the institutional level for surgical care.

    • Main Results:

    • Process-of-care trials offer a structured approach to quality improvement.
    • Potential for significant positive impact on patient outcomes.
    • Facilitates a better understanding and management of risks in surgical settings.

    Conclusions:

    • Surgical process-of-care trials are a valuable tool for enhancing healthcare quality.
    • They provide a framework for systematic improvement in surgical care delivery.
    • These trials can positively influence the culture and performance of healthcare institutions.